热门资讯> 正文
2025-10-28 19:31
Repligen (NASDAQ: RGEN) narrows FY2025 Adj EPS guidance from $1.65-$1.72 to $1.65-$1.68 vs $1.68 analyst estimate. Raises FY2025 sales outlook from $715.000 million-$735.000 million to $729.000 million-$737.000 million vs $726.458 million estimate.